Eyles, E. ., Margelyte, R. ., Edwards, H. B., Moran, P. A., Kessler, D. S., Davies, S. J. C., … Sullivan, S. A. (2023). Antipsychotic Medication and Risk of Metabolic Disorders in People With Schizophrenia: A Longitudinal Study Using the UK Clinical Practice Research Datalink. Schizophr Bull. http://doi.org/10.1093/schbul/sbad126
diabetes
Chudasama, Y. V., Khunti, K. ., Coles, B. ., Gillies, C. L., Islam, N. ., Rowlands, A. V., … Zaccardi, F. . (2023). Life expectancy following a cardiovascular event in individuals with and without type 2 diabetes: A UK multi-ethnic population-based observational study. Nutr Metab Cardiovasc Dis. http://doi.org/10.1016/j.numecd.2023.04.003
Cao, T. X. D., Filliter, C. ., Montastruc, F. ., H. Y. Yu, O. ., Fergusson, E. ., Rej, S. ., … Renoux, C. . (2022). Selective serotonin reuptake inhibitors and the risk of type 2 diabetes mellitus in youths. J Affect Disord, 318, 231–237. http://doi.org/10.1016/j.jad.2022.08.094
James, G. ., Kim, J. ., Mellström, C. ., Ford, K. L., Jenkins, N. C., Tsang, C. ., … McEwan, P. . (2022). Serum potassium variability as a predictor of clinical outcomes in patients with cardiorenal disease or diabetes: a retrospective UK database study. Clin Kidney J, 15, 758–770. http://doi.org/10.1093/ckj/sfab225